Key TakeawaysCagriSema showed superior weight reduction in REDEFINE 1 and 2 trials, outperforming existing interventions.REDEFINE 1 reported a 20.4% mean weight reduction with CagriSema, significantly higher than placebo.In REDEFINE 2, CagriSema achieved a 13.7% weight reduction and improved glycemic control in type 2 diabetes patients.Gastrointestinal adverse events were common but generally mild and transient.CagriSema shows […]
